Security
Sera Prognostics, Inc. Class A Common Stock · SERA
SERANASDAQCommon stockCurrentCIK 1534969Updated Nov 6, 2026
Name history
SERA PROGNOSTICS, INC. · through Nov 4, 2026
SERA price & chart
Loading TradingView…
NASDAQ:SERA on TradingView ↗About the company
Sera Prognostics is a leading health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera’s mission is to provide early, pivotal pregnancy information to improve the health of mothers and newborns, resulting in reductions in the costs of healthcare delivery. Sera has a robust pipeline of innovative diagnostic tests focused on the early prediction of preterm birth risk and other complications of pregnancy. Sera’s precision medicine PreTRM® Test reports to a physician the individualized risk of spontaneous premature delivery in a pregnancy, enabling earlier proactive interventions in women with higher risk. Sera Prognostics is headquartered in Salt Lake City, Utah.
In the news
SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS News provided by Sera Prognostics, Inc. Nov 13, 2025, 16:05 ET Share this article Share to X Share this article Share to X SALT LAKE CITY , Nov. 13, 2025 /PRNewswire/ -- Sera Prognostics Inc. , The Pregnancy Company® (Nasdaq: SERA ), foc ↗
Seeking Alpha
Sera Prognostics, Inc. (SERA) Q3 2026 Earnings Call Transcript ↗
Sera Prognostics appoints Scott Gleason as CFO, effective Aug. 31 ↗
Sera outlines 1%-2% Illinois Medicaid penetration in 2027 while targeting 5-7 commercial programs ↗
SEC disclosures
SERA PROGNOSTICS, INC. files 8-K: Material Event ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 108,125,000Source | 79,001,000Source | 86,737,000Source | 111,828,000Source | 84,861,000Source | 93,544,000Source | 118,184,000Source | 89,886,000Source | 101,933,000Source | 72,575,000Source | 95,441,000Source | 116,329,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 939,000Source | — | 888,000Source | 968,000Source | — | 881,000Source | 997,000Source | — | 910,000Source | 1,026,000Source | — | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 4,081,000Source | 2,684,000Source | 4,398,000Source | 5,016,000Source | 4,664,000Source | 4,175,000Source | 5,230,000Source | 4,239,000Source | 3,944,000Source | 4,043,000Source | 3,880,000Source | 29,878,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 14,000Source | 79,000Source | 10,000Source | 17,000Source | 101,000Source | 11,000Source | 25,000Source | 117,000Source | 12,000Source | 34,000Source | 160,000Source | 113,000Source |
| Assets, CurrentUSD | 44,491,000Source | 51,107,000Source | 48,134,000Source | 40,870,000Source | 51,543,000Source | 49,726,000Source | 47,283,000Source | 53,846,000Source | 40,770,000Source | 47,600,000Source | 61,344,000Source | 90,125,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,173,000Source | 1,276,000Source | 1,679,000Source | 693,000Source | 502,000Source | 2,314,000Source | 1,061,000Source | 756,000Source | 1,557,000Source | 1,311,000Source | 795,000Source | 1,308,000Source |
| Operating Lease, Right-of-Use AssetUSD | 2,460,000Source | 759,000Source | 2,306,000Source | 313,000Source | 902,000Source | 2,353,000Source | 464,000Source | 1,043,000Source | 2,402,000Source | 613,000Source | 1,180,000Source | 1,707,000Source |
| Other Assets, NoncurrentUSD | 2,583,000Source | 1,875,000Source | 2,480,000Source | 435,000Source | 1,705,000Source | 2,476,000Source | 588,000Source | 1,846,000Source | 2,525,000Source | 737,000Source | 1,257,000Source | 1,816,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 25,943,000Source | 24,350,000Source | 27,357,000Source | 23,602,000Source | 25,108,000Source | 25,924,000Source | 23,401,000Source | 25,136,000Source | 26,525,000Source | 24,772,000Source | 25,283,000Source | 17,386,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 4,000Source | 3,000Source | 4,000Source | 4,000Source | 3,000Source | 4,000Source | 4,000Source | 3,000Source | 4,000Source | 3,000Source | 3,000Source | 3,000Source |
| Additional Paid in CapitalUSD | 385,751,000Source | 325,571,000Source | 388,684,000Source | 384,104,000Source | 323,257,000Source | 387,721,000Source | 382,684,000Source | 319,921,000Source | 386,864,000Source | — | 317,066,000Source | 310,575,000Source |
| Retained Earnings (Accumulated Deficit)USD | -303,841,000Source | -271,215,000Source | -329,260,000Source | -296,027,000Source | -263,296,000Source | -320,121,000Source | -287,981,000Source | -254,993,000Source | -311,722,000Source | -279,794,000Source | -246,896,000Source | -210,654,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 268,000Source | 292,000Source | -48,000Source | 145,000Source | -211,000Source | 16,000Source | 76,000Source | -181,000Source | 262,000Source | 60,000Source | -15,000Source | -981,000Source |
| Stockholders' Equity Attributable to ParentUSD | 82,182,000Source | 54,651,000Source | 59,380,000Source | 88,226,000Source | 59,753,000Source | 67,620,000Source | 94,783,000Source | 64,750,000Source | 75,408,000Source | 47,803,000Source | 70,158,000Source | 98,943,000Source |
| Additional Paid in Capital, Common StockUSD | — | — | — | — | — | — | — | — | — | 327,534,000Source | — | — |
| Liabilities and EquityUSD | 108,125,000Source | 79,001,000Source | 86,737,000Source | 111,828,000Source | 84,861,000Source | 93,544,000Source | 118,184,000Source | 89,886,000Source | 101,933,000Source | 72,575,000Source | 95,441,000Source | 116,329,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 23,500,000Source | 24,182,000Source | 24,356,000Source | 23,602,000Source | 24,757,000Source | 23,419,000Source | 23,401,000Source | 24,568,000Source | 24,188,000Source | 24,770,000Source | 24,443,000Source | 15,538,000Source |
| Operating Lease, Liability, CurrentUSD | 0Source | 627,000Source | 0Source | 328,000Source | 610,000Source | 0Source | 487,000Source | 594,000Source | 0Source | 644,000Source | 578,000Source | 519,000Source |
| Accounts Payable, CurrentUSD | 1,037,000Source | 1,378,000Source | 1,190,000Source | 1,063,000Source | 952,000Source | 767,000Source | 1,207,000Source | 1,026,000Source | 862,000Source | 1,969,000Source | 1,046,000Source | 1,548,000Source |
| Operating Lease, Liability, NoncurrentUSD | 2,443,000Source | 165,000Source | 3,001,000Source | 0Source | 328,000Source | 2,505,000Source | 0Source | 487,000Source | 2,337,000Source | 0Source | 644,000Source | 1,222,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 193,000Source | 216,000Source | 940,000Source | 833,000Source | 900,000Source | 756,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 835,000Source | 1,493,000Source | 5,110,000Source | 7,013,000Source | 5,273,000Source | 5,055,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -1,000Source | -9,000Source | -22,000Source | -126,000Source | 47,000Source | 86,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -70,000Source | -996,000Source | -1,009,000Source | 455,000Source | -442,000Source | 352,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -8,774,000Source | -7,553,000Source | -25,623,000Source | -14,189,000Source | -27,188,000Source | -34,610,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 8,985,000Source | -44,802,000Source | -28,502,000Source | 11,743,000Source | 438,000Source | 5,551,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 8,000Source | 3,000Source | 726,000Source | 56,000Source | 128,000Source | 791,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 20,000Source | 53,542,000Source | 54,026,000Source | 2,609,000Source | 752,000Source | 5,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 4,081,000Source | 2,684,000Source | 4,398,000Source | 5,016,000Source | 4,175,000Source | 5,230,000Source | 3,944,000Source | 4,043,000Source | 3,880,000Source | 29,878,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 2,000Source | 4,000Source | 9,000Source | 28,000Source | 55,000Source | 48,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 1,254,000Source | 1,680,000Source | 823,000Source | 1,344,000Source | 835,000Source | 1,493,000Source | 5,110,000Source | 7,013,000Source | 5,273,000Source | 5,055,000Source |
| Amortization of Intangible AssetsUSD | — | — | 29,000Source | 0Source | 29,000Source | 29,000Source | 29,000Source | 29,000Source | 116,000Source | 19,000Source | — | — |
| DepreciationUSD | — | — | 200,000Source | 200,000Source | 200,000Source | 200,000Source | 200,000Source | 200,000Source | 800,000Source | — | — | — |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| General and Administrative ExpenseUSD | — | — | 4,079,000Source | 4,195,000Source | 4,248,000Source | 4,138,000Source | 4,290,000Source | 4,444,000Source | 16,702,000Source | 16,129,000Source | 16,343,000Source | 16,784,000Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -7,814,000Source | -7,919,000Source | -9,139,000Source | -8,046,000Source | -8,399,000Source | -8,187,000Source | -31,928,000Source | -32,898,000Source | -36,242,000Source | -44,186,000Source |
| Nonoperating Income (Expense)USD | — | — | 1,168,000Source | 948,000Source | 867,000Source | 1,276,000Source | 963,000Source | 1,067,000Source | 4,585,000Source | 3,765,000Source | 3,634,000Source | 1,527,000Source |
| Operating ExpensesUSD | — | — | 8,996,000Source | 8,891,000Source | 10,034,000Source | 9,337,000Source | 9,374,000Source | 9,288,000Source | 36,585,000Source | 36,712,000Source | 40,127,000Source | 45,920,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 0Source | 53,610,000Source | 53,610,000Source | — | — | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 22,000Source | 47,000Source | 507,000Source | 2,902,000Source | 1,095,000Source | 308,000Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 16,000Source | 29,000Source | 30,000Source | 17,000Source | 14,000Source | 38,000Source | 81,000Source | 77,000Source | 306,000Source | 268,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | — | — |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Income (Loss)USD | — | — | -8,980,000Source | -8,862,000Source | -10,004,000Source | -9,320,000Source | -9,360,000Source | -9,250,000Source | -36,504,000Source | -36,635,000Source | -39,821,000Source | -45,652,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | -31,928,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -7,814,000Source | -7,919,000Source | -9,139,000Source | -8,046,000Source | -8,399,000Source | -8,187,000Source | -31,928,000Source | -32,898,000Source | -36,242,000Source | -44,186,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.16Source | -0.24Source | -0.18Source | -0.16Source | -0.17Source | -0.2Source | -0.67Source | -0.99Source | -1.16Source | -1.43Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.16Source | -0.24Source | -0.18Source | -0.16Source | -0.17Source | -0.2Source | -0.67Source | -0.99Source | -1.16Source | -1.43Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 49,525,108Source | 33,522,726Source | 50,476,874Source | 49,066,398Source | 50,258,849Source | 41,968,076Source | 47,662,078Source | 33,156,936Source | 31,200,652Source | 30,943,426Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 49,525,108Source | 33,522,726Source | 50,476,874Source | 49,066,398Source | 50,258,849Source | 41,968,076Source | 47,662,078Source | 33,156,936Source | 31,200,652Source | 30,943,426Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 29,000Source | 0Source | 29,000Source | 29,000Source | 29,000Source | 29,000Source | 116,000Source | 19,000Source | — | — |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 214,000Source | 201,000Source | 162,000Source | 208,000Source | 164,000Source | 187,000Source | 824,000Source | 814,000Source | — | — |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| General and Administrative ExpenseUSD | — | — | 4,079,000Source | 4,195,000Source | 4,248,000Source | 4,138,000Source | 4,290,000Source | 4,444,000Source | 16,702,000Source | 16,129,000Source | 16,343,000Source | 16,784,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -31,928,000Source | — | — | — |
| Interest ExpenseUSD | — | — | 2,000Source | 5,000Source | 2,000Source | 2,000Source | 2,000Source | 4,000Source | 9,000Source | 28,000Source | — | — |
| Interest Income, OtherUSD | — | — | 1,102,000Source | 733,000Source | 820,000Source | 1,194,000Source | 937,000Source | 921,000Source | 4,253,000Source | 2,747,000Source | 1,640,000Source | 456,000Source |
| Nonoperating Income (Expense)USD | — | — | 1,168,000Source | 948,000Source | 867,000Source | 1,276,000Source | 963,000Source | 1,067,000Source | 4,585,000Source | 3,765,000Source | 3,634,000Source | 1,527,000Source |
| Operating ExpensesUSD | — | — | 8,996,000Source | 8,891,000Source | 10,034,000Source | 9,337,000Source | 9,374,000Source | 9,288,000Source | 36,585,000Source | 36,712,000Source | 40,127,000Source | 45,920,000Source |
| Research and Development ExpenseUSD | — | — | 3,284,000Source | 3,502,000Source | 3,493,000Source | 3,337,000Source | 3,030,000Source | 3,334,000Source | 13,171,000Source | 14,730,000Source | 15,225,000Source | 14,244,000Source |
| Selling and Marketing ExpenseUSD | — | — | 1,592,000Source | 1,181,000Source | 2,243,000Source | 1,821,000Source | 2,012,000Source | 1,470,000Source | 6,548,000Source | 5,771,000Source | 8,349,000Source | 14,699,000Source |
Filing attachments
sera-ex99_1.htm · 8-K · 2026-11-04
Exhibit 99.1 SERA PROGNOSTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS Company Drives Significant Increases in Test Volume and Ordering Providers with Florida Becoming Second Medicaid State Covering Test • PreTRM® test volume increases 54% sequentially and approximately five-fold from 1Q26 • Ordering healthcare providers increase 34% sequentially and approximately three-fold from 1Q26 • Florida provides Medicaid coverage for PreTRM® with established fee schedule pricing • PreTRM® menti…
Read attachment ↗d417235dex991.htm · 8-K · 2026-08-19
EX-99.1 4 d417235dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER Salt Lake City - August 19, 2026 - Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, announced today that Scott Gleason has been appointed Chief Financial Officer (CFO), effective August 31, 2026. Mr. Gleason brings more than 25…
Read attachment ↗sera-ex99_1.htm · 8-K · 2026-08-12
EX-99.1 2 sera-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 SERA PROGNOSTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS Salt Lake City - August 12, 2026 - Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the second quarter ended June 30, 2026. Key Second Quarter and Recent Highlights: • Advanced Commercial Ado…
Read attachment ↗sera-ex99_1.htm · 8-K · 2026-06-30
EX-99.1 3 sera-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS Salt Lake City - June 30, 2026 - Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that Mark Capone will join its Board of Directors, effective July 1, 2026. Mr. Capone is a seasoned healthcare exec…
Read attachment ↗sera-ex99_1.htm · 8-K · 2026-06-01
EX-99.1 2 sera-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION Salt Lake City - June 1, 2026 - Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that Jeff Elliott has notified the Company of his intention to step down from its Board of Directors, effective June 4, 2026, and that he will not stand …
Read attachment ↗sera-ex99_1.htm · 8-K · 2026-05-06
EX-99.1 2 sera-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 SERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS Salt Lake City - May 6, 2026 - Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the first quarter ended March 31, 2026. Key First Quarter and Recent Highlights: • Published Landmark PRIME Rand…
Read attachment ↗